Markel Group Inc. (NYSE:MKL – Get Free Report) has received an average recommendation of “Reduce” from the six research firms that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and five have issued a hold rating on the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $2,025.00.
Several equities analysts recently issued reports on the company. Truist Financial reduced their price objective on Markel Group from $2,100.00 to $1,950.00 and set a “hold” rating on the stock in a research note on Thursday, April 30th. Wolfe Research began coverage on shares of Markel Group in a research note on Wednesday, July 1st. They set an “underperform” rating for the company. Brean Capital initiated coverage on shares of Markel Group in a report on Tuesday, March 24th. They set a “neutral” rating and a $2,100.00 target price on the stock. Weiss Ratings downgraded shares of Markel Group from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, June 11th. Finally, Wall Street Zen lowered shares of Markel Group from a “buy” rating to a “sell” rating in a report on Saturday, May 2nd.
View Our Latest Report on Markel Group
Markel Group Trading Down 0.9%
Markel Group (NYSE:MKL – Get Free Report) last issued its earnings results on Tuesday, April 28th. The insurance provider reported ($18.90) EPS for the quarter, missing the consensus estimate of $26.38 by ($45.28). Markel Group had a return on equity of 7.90% and a net margin of 10.85%.The firm had revenue of $3.55 billion during the quarter, compared to analyst estimates of $3.66 billion. On average, analysts predict that Markel Group will post 114.11 EPS for the current year.
Insider Transactions at Markel Group
In other Markel Group news, Director Greta J. Harris sold 76 shares of Markel Group stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $1,847.31, for a total value of $140,395.56. Following the completion of the transaction, the director directly owned 645 shares in the company, valued at $1,191,514.95. The trade was a 10.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Diane Leopold bought 100 shares of the stock in a transaction dated Wednesday, May 6th. The shares were bought at an average cost of $1,792.61 per share, with a total value of $179,261.00. Following the completion of the acquisition, the director directly owned 2,190 shares of the company’s stock, valued at approximately $3,925,815.90. The trade was a 4.78% increase in their position. The disclosure for this purchase is available in the SEC filing. Company insiders own 1.08% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the stock. Brighton Jones LLC acquired a new stake in Markel Group in the fourth quarter worth $236,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Markel Group by 13.5% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 109 shares of the insurance provider’s stock valued at $204,000 after acquiring an additional 13 shares during the period. Goldman Sachs Group Inc. grew its position in shares of Markel Group by 9.7% during the first quarter. Goldman Sachs Group Inc. now owns 34,704 shares of the insurance provider’s stock worth $64,883,000 after acquiring an additional 3,083 shares during the last quarter. Empowered Funds LLC grew its position in shares of Markel Group by 49.1% during the first quarter. Empowered Funds LLC now owns 416 shares of the insurance provider’s stock worth $778,000 after acquiring an additional 137 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new stake in shares of Markel Group in the 2nd quarter worth about $463,000. 77.12% of the stock is currently owned by institutional investors.
About Markel Group
Markel Group (NYSE: MKL) is a diversified insurance holding company best known for underwriting specialty insurance products. Founded in 1930 and headquartered in Richmond, Virginia, the company provides a wide range of commercial property and casualty coverages tailored to niche and hard-to-place risks. Its underwriting operations focus on specialty lines across multiple industries, delivering customized policy structures, program administration, and claims management services for complex exposures.
In addition to primary specialty insurance, Markel operates reinsurance and alternative risk-transfer activities and manages invested assets derived from underwriting float.
Featured Stories
- Five stocks we like better than Markel Group
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.
